Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 35, Issue 6, 2005, Pages 577-582

  Chizuka, A ^a   Kami, M ^a   Kanda, Y ^b   Murashige, N ^a   Kishi, Y ^a   Hamaki, T ^a   Kim, S W ^a   Hori, A ^a   Kojima, R ^a   Mori, S I ^a   Tanosaki, R ^a   Gomi, H ^c   Takaue, Y ^c  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Japan   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Bloodstream infection; Graft versus host disease

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; BETA LACTAM; BUSULFAN; CIPROFLOXACIN; CLADRIBINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUCONAZOLE; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ACINETOBACTER LWOFFII; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; BLOOD CULTURE; BODY TEMPERATURE; CAUSE OF DEATH; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; DRUG DOSE REGIMEN; ENTEROCOCCUS FAECALIS; FEBRILE NEUTROPENIA; FEMALE; FUNGEMIA; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDWELLING CATHETER; INFLAMMATION; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PATIENT MONITORING; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; BACTEREMIA; BACTERIA; BACTERIOLOGICAL TECHNIQUES; CATHETERIZATION, CENTRAL VENOUS; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDNISOLONE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 20144388109     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704830     Document Type: Article

References (27)

1. Collin BA, Leather HL, Wingard JR et al. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947-953.
2. Kruger W, Russmann B, Kroger N et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation - a 7 year single centre investigation of 409 cases. Bone Marrow Transplant 1999; 23: 589-597.
3. Mohty M, Faucher C, Vey N et al. High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation. Bone Marrow Transplant 2000; 26: 251-255.
4. Ninin E, Milpied N, Moreau P et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001; 33: 41-47.
5. Junghanss C, Boeckh M, Carter RA et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 2002; 99: 1978-1985.
6. Arns da Cunha C, Weisdorf D, Shu XO et al. Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant 1998; 21: 173-180.
7. Kolbe K, Domkin D, Derigs HG et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143-147.
8. Sparrelid E, Hagglund H, Remberger M et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant 1998; 22: 795-800.
9. Anonymous. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Ann Intern Med 1993; 119 (Part 1): 584-593.
10. Anonymous. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. The EORTC International Antimicrobial Therapy Cooperative Group. N Engl J Med 1987; 317: 1692-1698.
11. Sayer HG, Longton G, Bowden R et al. Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood 1994; 84: 1328-1332.
12. Wisplinghoff H, Seifert H, Wenzel RP et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36: 1103-1110.
13. Woo PC, Wong SS, Lum PN et al. Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients. Lancet 2001; 357: 675-679.
14. Kami M, Hamaki T, Kusumi E et al. Cell-wall-deficient bacteria. Lancet 2001; 357: 1885-1886.
15. Serody JS, Berrey MM, Albritton K et al. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant 2000; 26: 533-538.
16. Levin PD, Hersch M, Rudensky B et al. Routine surveillance blood cultures: their place in the management of critically ill patients. J Infect 1997; 35: 125-128.
17. Anonymous. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000; 6: 659-713.
18. Garner J, Jarvis W, Emori T et al. CDC definitions for nosocomial infections. In: Olmsted R (ed.). APIC Infection Control and Applied Epidemiology. Mosby: St Louis, 1996, pp A1-A20.
19. Weinstein MP, Towns ML, Quartey SM et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24 584-602.
20. Kanda Y, Mineishi S, Saito T et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 689-692.
21. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-751.
22. Engelhard D, Elishoov H, Strauss N et al. Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. Transplantation 1996; 61: 430-434.
23. Engels EA, Ellis CA, Supran SE et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999; 28: 256-266.
24. Aronson MD, Bor DH. Blood cultures. Ann Intern Med 1987; 106: 246-253.
25. Grace CJ, Lieberman J, Pierce K et al. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 2001; 32: 1651-1655.
26. Lina B, Forey F, Tigaud JD et al. Chronic bacteraemia due to Staphylococcus epidermidis after bone marrow transplantation. J Med Microbiol 1995; 42: 156-160.
27. Engels EA, Lau J, Barza M. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 1998; 16: 1179-1187.